TMEM30CP: A Protein Involved in Ion Channel Regulation and Cell Signaling

Target Name: TMEM30CP

NCBI ID: G644444

TMEM30CP

Other Name(s): TMEM30CP variant 1 | CDC50C | Transmembrane protein 30C, pseudogene, transcript variant 1 | TMEM30C | transmembrane protein 30C, pseudogene

TMEM30CP: A Protein Involved in Ion Channel Regulation and Cell Signaling

TMEM30CP (TMEM30CP variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the transmembrane protein family, which means that it spans the cell membrane and functions as a protein that interacts with other proteins in the same membrane. TMEM30CP is involved in a number of cellular processes that are important for maintaining tissue health and function.

One of the key functions of TMEM30CP is its role in the regulation of ion channels. These channels are responsible for the flow of electrical current through the cell membrane, and they play a crucial role in the proper functioning of many cellular processes. TMEM30CP is involved in the regulation of the type of ion channels that are present in the cell membrane, as well as the levels of certain ions within the channels.

In addition to its role in ion channel regulation, TMEM30CP is also involved in the regulation of cell signaling processes. This involves the transfer of signals from the cell surface to the cell interior, and it is a critical component of many signaling pathways that are important for cellular growth, development, and survival.

Another function of TMEM30CP is its role in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs, and it is a critical aspect of many biological processes, including embryonic development and tissue repair. TMEM30CP is involved in the regulation of cell adhesion by controlling the formation of tight junctions, which are the gaps that form between adjacent cells.

In addition to its roles in ion channel regulation, signaling, and cell adhesion, TMEM30CP is also involved in the regulation of a number of other cellular processes. This includes the regulation of cell signaling pathways, the production of certain proteins, and the regulation of cellular uptake and release of certain substances.

TMEM30CP is a potential drug target because of its involvement in a number of important cellular processes. Many diseases, including those that affect the brain, heart, and kidneys, are caused by the disruption of these processes. For example, conditions such as Alzheimer's disease, Parkinson's disease, and nephrotic syndrome are all characterized by the misregulation of ion channels and signaling pathways, and these conditions could be treated with drugs that target TMEM30CP. Additionally, TMEM30CP is also a potential biomarker for certain diseases, as the levels of this protein can be affected by a variety of factors, including changes in cellular signaling pathways.

In conclusion, TMEM30CP is a transmembrane protein that is involved in a number of important cellular processes. Its regulation of ion channels, signaling, and cell adhesion makes it a potential drug target and a valuable biomarker for the treatment of a variety of diseases. Further research is needed to fully understand the role of TMEM30CP in cellular processes and to develop effective treatments for the disorders that are caused by its disruption.

Protein Name: Transmembrane Protein 30C, Pseudogene

The "TMEM30CP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM30CP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets